Project Grant HT9425261E147
Award Date 5/15/26
Completion Date 4/14/29
Dollars Obligated $1.9M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Palo Alto, CA 94305, USA
Similar Awards
- Federal Grant Award Summary The Defense Health Agency awarded The Leland Stanford Junior University a $604,151 Project Grant on May 15, 2026, under the Military Medical Research and Development program (CFDA 12.420) to conduct research on therapeutic inactivation of the MYC oncogene as a treatment for triple negative breast cancer. The three-year research initiative, scheduled for completion by May 14, 2029, will be conducted at Stanford's Palo Alto, California facility. This award supports...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a $1.82M project grant effective May 1, 2026, through April 30, 2030, under the Military Medical Research and Development program (CFDA 12.420). The award supports development of a predictive spatial assay designed to eliminate unnecessary therapeutic interventions in primary ductal carcinoma in situ (DCIS), a form of breast cancer. This research initiative represents a translational...
- The Leland Stanford Junior University was awarded a $4.72 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from March 2021 through March 2025 relating the interplay of tumor function and host response to clinical outcome in triple negative breast cancer. Through this award, Stanford University researchers will investigate medical solutions for breast cancer on the battlefield and...
- The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $1,795,499 project grant to The Leland Stanford Junior University, doing business as Stanford University, to conduct an evaluation of clinical responders with advanced triple-negative breast cancer from the KEYNOTE-890 study. The purpose of this 4-year project is to validate a published CXCR3 gene signature that may help identify patients likely to respond to certain cancer...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a $1.528 million project grant on May 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to develop a predictive spatial assay for eliminating unnecessary therapies in primary ductal carcinoma in situ (DCIS). The four-year award, with an ultimate completion date of April 30, 2030, supports advanced biomedical research aimed at improving cancer...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a $7.0 million Project Grant on April 15, 2026, under the Military Medical Research and Development program (CFDA 12.420) to support the TAILORX Clinical Research Extension Award: Advancing Breast Cancer Treatment Stratification Through Spatial Omics and Digital Pathology. The four-year award, with a completion date of April 14, 2030, will be performed at Stanford's Palo Alto, CA location...
- This $469,381.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by The Leland Stanford Junior University (Stanford University) to engineer cytotoxic lymphocytes to infiltrate ovarian cancer tumors via metabolite-sensing receptors. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing medical solutions for critical health...
- This $370,866 Formula Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research conducted by The Leland Stanford Junior University, a prominent private research university. The grant will fund a 1-year project to uncover synthetically lethal genes that could be targeted in lung cancer in the presence of protein folding stress, with the goal of transforming healthcare for military service members...
- This $926,400 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to The Leland Stanford Junior University. The grant will fund a 3-year research project to conduct an "Integrated Immunophenotypic Transcriptomic and Epigenomic Characterization of Uterine Mesenchymal Neoplasms with Expert Pathologist Panel Review". The objectives are to advance scientific understanding and develop new treatments for these...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,191,941 to The Leland Stanford Junior University (Stanford University) from July 15, 2023 through July 14, 2027. The purpose of the grant is to conduct research on "Targeting Unusual Nutrient Acquisition Routes of Nutrient-Deprived Cancers." As a highly-regarded private research university, Stanford University has a history of providing...